AKT1 and chronic obstructive pulmonary disease: Mercado et al. (2011) found that nortriptyline pretreatment inhibited Akt phosphorylation and PI3K activity, restoring oxidative stress-induced corticosteroid sensitivity as a potential treatment for respiratory diseases such as COPD that are corticosteroid insensitive.